+Follow
Lhgoh
No personal profile
47
Follow
4
Followers
0
Topic
0
Badge
Posts
Hot
Lhgoh
2021-09-04
Patience
@LittlePotato:
$Bank of America(BAC)$
amazing
Lhgoh
2021-08-30
Patienece is the key
@专业赌徒:
$Alibaba(BABA)$
accumulate
Lhgoh
2021-08-26
$Alibaba(BABA)$
come on
Lhgoh
2021-08-23
Not bad
Pfizer to Acquire Cancer Drugmaker Trillium for $2.3 Billion
Lhgoh
2021-08-23
Like
Sorry, the original content has been removed
Lhgoh
2021-08-23
Wow
Sorry, the original content has been removed
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3583662534350147","uuid":"3583662534350147","gmtCreate":1620569284793,"gmtModify":1629724031520,"name":"Lhgoh","pinyin":"lhgoh","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/1c2aee9a5977b03cf1fb62e2691c9aee","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":47,"tweetSize":8,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.02.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"60.61%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":814948146,"gmtCreate":1630752010585,"gmtModify":1676530390361,"author":{"id":"3583662534350147","authorId":"3583662534350147","name":"Lhgoh","avatar":"https://static.tigerbbs.com/1c2aee9a5977b03cf1fb62e2691c9aee","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583662534350147","authorIdStr":"3583662534350147"},"themes":[],"htmlText":"Patience","listText":"Patience","text":"Patience","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/814948146","repostId":"812704397","repostType":1,"repost":{"id":812704397,"gmtCreate":1630622463819,"gmtModify":1676530356432,"author":{"id":"4087255023642500","authorId":"4087255023642500","name":"LittlePotato","avatar":"https://static.itradeup.com/news/b42a82452aff8b563c6f332c56ef8a9a","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087255023642500","authorIdStr":"4087255023642500"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>amazing","listText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>amazing","text":"$Bank of America(BAC)$amazing","images":[{"img":"https://static.tigerbbs.com/6d44bc628b4a582065dc666692022ba7","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/812704397","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":680,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":811823311,"gmtCreate":1630311066033,"gmtModify":1676530264395,"author":{"id":"3583662534350147","authorId":"3583662534350147","name":"Lhgoh","avatar":"https://static.tigerbbs.com/1c2aee9a5977b03cf1fb62e2691c9aee","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583662534350147","authorIdStr":"3583662534350147"},"themes":[],"htmlText":"Patienece is the key","listText":"Patienece is the key","text":"Patienece is the key","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/811823311","repostId":"811880513","repostType":1,"repost":{"id":811880513,"gmtCreate":1630308783732,"gmtModify":1676530263682,"author":{"id":"3581384167040593","authorId":"3581384167040593","name":"专业赌徒","avatar":"https://static.tigerbbs.com/72d9e618e4147067f493bea090e2c5c6","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581384167040593","authorIdStr":"3581384167040593"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>accumulate","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>accumulate","text":"$Alibaba(BABA)$accumulate","images":[{"img":"https://static.tigerbbs.com/3de793187f3a99b4520c636da8660b19","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/811880513","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":621,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810401281,"gmtCreate":1629989553643,"gmtModify":1676530195069,"author":{"id":"3583662534350147","authorId":"3583662534350147","name":"Lhgoh","avatar":"https://static.tigerbbs.com/1c2aee9a5977b03cf1fb62e2691c9aee","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583662534350147","authorIdStr":"3583662534350147"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>come on","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>come on","text":"$Alibaba(BABA)$come on","images":[{"img":"https://static.tigerbbs.com/7a2fb32cad18084c3c3d3ed5b1a9cbc2","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/810401281","isVote":1,"tweetType":1,"viewCount":682,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":835261682,"gmtCreate":1629721420846,"gmtModify":1676530110777,"author":{"id":"3583662534350147","authorId":"3583662534350147","name":"Lhgoh","avatar":"https://static.tigerbbs.com/1c2aee9a5977b03cf1fb62e2691c9aee","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583662534350147","authorIdStr":"3583662534350147"},"themes":[],"htmlText":"Not bad","listText":"Not bad","text":"Not bad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/835261682","repostId":"1140755633","repostType":4,"repost":{"id":"1140755633","kind":"news","pubTimestamp":1629717900,"share":"https://ttm.financial/m/news/1140755633?lang=&edition=fundamental","pubTime":"2021-08-23 19:25","market":"us","language":"en","title":"Pfizer to Acquire Cancer Drugmaker Trillium for $2.3 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1140755633","media":"Bloomberg","summary":"Pfizer Inc., maker of a top-selling Covid vaccine, will buy all the shares of Trillium Therapeutics ","content":"<p>Pfizer Inc., maker of a top-selling Covid vaccine, will buy all the shares of Trillium Therapeutics Inc.it doesn’t own, gaining the immune cancer drugmaker for an equity value of $2.26 billion.</p>\n<p>Pfizer will pay $18.50 a share for Cambridge, Massachusetts-based Trillium, the companies said Monday in a statement. The price represents a 118% premium to the stock’s 60-day weighted average price.</p>\n<p>Pfizer invested $25 million in Trillium in September as part of its Breakthrough Growth Initiative, when Jeff Settleman, senior vice president of Pfizer’s oncology research and development group, was named to Trillium’s scientific advisory board.</p>\n<p>Trillium’s two lead molecules, TTI-622 and TTI-621, block signaling proteins involved in blood cancers, and are both in human trials across several types of disease.</p>\n<p>Shares of Trillium nearly tripled in trading before U.S. markets opened, while Pfizer rose 3.8%.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer to Acquire Cancer Drugmaker Trillium for $2.3 Billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer to Acquire Cancer Drugmaker Trillium for $2.3 Billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-23 19:25 GMT+8 <a href=https://www.bloomberg.com/news/articles/2021-08-23/pfizer-to-acquire-cancer-drugmaker-trillium-for-2-3-billion?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer Inc., maker of a top-selling Covid vaccine, will buy all the shares of Trillium Therapeutics Inc.it doesn’t own, gaining the immune cancer drugmaker for an equity value of $2.26 billion.\nPfizer...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-08-23/pfizer-to-acquire-cancer-drugmaker-trillium-for-2-3-billion?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","TRIL":"Trillium Therapeutics Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-08-23/pfizer-to-acquire-cancer-drugmaker-trillium-for-2-3-billion?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140755633","content_text":"Pfizer Inc., maker of a top-selling Covid vaccine, will buy all the shares of Trillium Therapeutics Inc.it doesn’t own, gaining the immune cancer drugmaker for an equity value of $2.26 billion.\nPfizer will pay $18.50 a share for Cambridge, Massachusetts-based Trillium, the companies said Monday in a statement. The price represents a 118% premium to the stock’s 60-day weighted average price.\nPfizer invested $25 million in Trillium in September as part of its Breakthrough Growth Initiative, when Jeff Settleman, senior vice president of Pfizer’s oncology research and development group, was named to Trillium’s scientific advisory board.\nTrillium’s two lead molecules, TTI-622 and TTI-621, block signaling proteins involved in blood cancers, and are both in human trials across several types of disease.\nShares of Trillium nearly tripled in trading before U.S. markets opened, while Pfizer rose 3.8%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":724,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835269245,"gmtCreate":1629721244687,"gmtModify":1676530110730,"author":{"id":"3583662534350147","authorId":"3583662534350147","name":"Lhgoh","avatar":"https://static.tigerbbs.com/1c2aee9a5977b03cf1fb62e2691c9aee","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583662534350147","authorIdStr":"3583662534350147"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/835269245","repostId":"1175882737","repostType":4,"isVote":1,"tweetType":1,"viewCount":709,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835269349,"gmtCreate":1629721177781,"gmtModify":1676530110738,"author":{"id":"3583662534350147","authorId":"3583662534350147","name":"Lhgoh","avatar":"https://static.tigerbbs.com/1c2aee9a5977b03cf1fb62e2691c9aee","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583662534350147","authorIdStr":"3583662534350147"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/835269349","repostId":"1145556595","repostType":4,"isVote":1,"tweetType":1,"viewCount":866,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":835261682,"gmtCreate":1629721420846,"gmtModify":1676530110777,"author":{"id":"3583662534350147","authorId":"3583662534350147","name":"Lhgoh","avatar":"https://static.tigerbbs.com/1c2aee9a5977b03cf1fb62e2691c9aee","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583662534350147","authorIdStr":"3583662534350147"},"themes":[],"htmlText":"Not bad","listText":"Not bad","text":"Not bad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/835261682","repostId":"1140755633","repostType":4,"repost":{"id":"1140755633","kind":"news","pubTimestamp":1629717900,"share":"https://ttm.financial/m/news/1140755633?lang=&edition=fundamental","pubTime":"2021-08-23 19:25","market":"us","language":"en","title":"Pfizer to Acquire Cancer Drugmaker Trillium for $2.3 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1140755633","media":"Bloomberg","summary":"Pfizer Inc., maker of a top-selling Covid vaccine, will buy all the shares of Trillium Therapeutics ","content":"<p>Pfizer Inc., maker of a top-selling Covid vaccine, will buy all the shares of Trillium Therapeutics Inc.it doesn’t own, gaining the immune cancer drugmaker for an equity value of $2.26 billion.</p>\n<p>Pfizer will pay $18.50 a share for Cambridge, Massachusetts-based Trillium, the companies said Monday in a statement. The price represents a 118% premium to the stock’s 60-day weighted average price.</p>\n<p>Pfizer invested $25 million in Trillium in September as part of its Breakthrough Growth Initiative, when Jeff Settleman, senior vice president of Pfizer’s oncology research and development group, was named to Trillium’s scientific advisory board.</p>\n<p>Trillium’s two lead molecules, TTI-622 and TTI-621, block signaling proteins involved in blood cancers, and are both in human trials across several types of disease.</p>\n<p>Shares of Trillium nearly tripled in trading before U.S. markets opened, while Pfizer rose 3.8%.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer to Acquire Cancer Drugmaker Trillium for $2.3 Billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer to Acquire Cancer Drugmaker Trillium for $2.3 Billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-23 19:25 GMT+8 <a href=https://www.bloomberg.com/news/articles/2021-08-23/pfizer-to-acquire-cancer-drugmaker-trillium-for-2-3-billion?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer Inc., maker of a top-selling Covid vaccine, will buy all the shares of Trillium Therapeutics Inc.it doesn’t own, gaining the immune cancer drugmaker for an equity value of $2.26 billion.\nPfizer...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-08-23/pfizer-to-acquire-cancer-drugmaker-trillium-for-2-3-billion?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","TRIL":"Trillium Therapeutics Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-08-23/pfizer-to-acquire-cancer-drugmaker-trillium-for-2-3-billion?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140755633","content_text":"Pfizer Inc., maker of a top-selling Covid vaccine, will buy all the shares of Trillium Therapeutics Inc.it doesn’t own, gaining the immune cancer drugmaker for an equity value of $2.26 billion.\nPfizer will pay $18.50 a share for Cambridge, Massachusetts-based Trillium, the companies said Monday in a statement. The price represents a 118% premium to the stock’s 60-day weighted average price.\nPfizer invested $25 million in Trillium in September as part of its Breakthrough Growth Initiative, when Jeff Settleman, senior vice president of Pfizer’s oncology research and development group, was named to Trillium’s scientific advisory board.\nTrillium’s two lead molecules, TTI-622 and TTI-621, block signaling proteins involved in blood cancers, and are both in human trials across several types of disease.\nShares of Trillium nearly tripled in trading before U.S. markets opened, while Pfizer rose 3.8%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":724,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":811823311,"gmtCreate":1630311066033,"gmtModify":1676530264395,"author":{"id":"3583662534350147","authorId":"3583662534350147","name":"Lhgoh","avatar":"https://static.tigerbbs.com/1c2aee9a5977b03cf1fb62e2691c9aee","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583662534350147","authorIdStr":"3583662534350147"},"themes":[],"htmlText":"Patienece is the key","listText":"Patienece is the key","text":"Patienece is the key","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/811823311","repostId":"811880513","repostType":1,"repost":{"id":811880513,"gmtCreate":1630308783732,"gmtModify":1676530263682,"author":{"id":"3581384167040593","authorId":"3581384167040593","name":"专业赌徒","avatar":"https://static.tigerbbs.com/72d9e618e4147067f493bea090e2c5c6","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581384167040593","authorIdStr":"3581384167040593"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>accumulate","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>accumulate","text":"$Alibaba(BABA)$accumulate","images":[{"img":"https://static.tigerbbs.com/3de793187f3a99b4520c636da8660b19","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/811880513","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":621,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835269349,"gmtCreate":1629721177781,"gmtModify":1676530110738,"author":{"id":"3583662534350147","authorId":"3583662534350147","name":"Lhgoh","avatar":"https://static.tigerbbs.com/1c2aee9a5977b03cf1fb62e2691c9aee","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583662534350147","authorIdStr":"3583662534350147"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/835269349","repostId":"1145556595","repostType":4,"repost":{"id":"1145556595","kind":"news","pubTimestamp":1629719346,"share":"https://ttm.financial/m/news/1145556595?lang=&edition=fundamental","pubTime":"2021-08-23 19:49","market":"us","language":"en","title":"HSBC Hong Kong CEO Cesar Takes Top Job at Hang Seng Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=1145556595","media":"Bloomberg","summary":"HSBC Holdings Plc’s chief executive officer of Hong Kong has been appointed to the top job at Hang S","content":"<p>HSBC Holdings Plc’s chief executive officer of Hong Kong has been appointed to the top job at Hang Seng Bank Ltd.</p>\n<p>Diana Cesar will succeed Louisa Cheang on Sept. 1, according to an emailed statement from the bank. HSBC has started a process to find a new CEO for its Hong Kong business.</p>\n<p>Luanne Lim, the chief operating officer at HSBC in Hong Kong, will assume the role of interim chief executive for the operations in the city until a successor is appointed. Louisa Cheang, the chief executive of Hang Seng, will extend her leave of absence while she receives medical treatment and return as an HSBC executive “in due course,” the statement said.</p>\n<p>HSBC, Europe’s largest lender, is steering billions of dollars in capital toward Asia to lift its profitability while shrinking or exiting operations in other parts of the world. Key to its growth strategy in Greater China is capitalizing on the rising affluence in the world’s second-largest economy.</p>\n<p>The London-based bank owns about 62% of Hang Seng.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HSBC Hong Kong CEO Cesar Takes Top Job at Hang Seng Bank</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHSBC Hong Kong CEO Cesar Takes Top Job at Hang Seng Bank\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-23 19:49 GMT+8 <a href=https://www.bloomberg.com/news/articles/2021-08-23/hsbc-hong-kong-ceo-cesar-takes-top-job-at-hang-seng-bank><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HSBC Holdings Plc’s chief executive officer of Hong Kong has been appointed to the top job at Hang Seng Bank Ltd.\nDiana Cesar will succeed Louisa Cheang on Sept. 1, according to an emailed statement ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-08-23/hsbc-hong-kong-ceo-cesar-takes-top-job-at-hang-seng-bank\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HSBC":"汇丰","00005":"汇丰控股","00011":"恒生银行"},"source_url":"https://www.bloomberg.com/news/articles/2021-08-23/hsbc-hong-kong-ceo-cesar-takes-top-job-at-hang-seng-bank","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1145556595","content_text":"HSBC Holdings Plc’s chief executive officer of Hong Kong has been appointed to the top job at Hang Seng Bank Ltd.\nDiana Cesar will succeed Louisa Cheang on Sept. 1, according to an emailed statement from the bank. HSBC has started a process to find a new CEO for its Hong Kong business.\nLuanne Lim, the chief operating officer at HSBC in Hong Kong, will assume the role of interim chief executive for the operations in the city until a successor is appointed. Louisa Cheang, the chief executive of Hang Seng, will extend her leave of absence while she receives medical treatment and return as an HSBC executive “in due course,” the statement said.\nHSBC, Europe’s largest lender, is steering billions of dollars in capital toward Asia to lift its profitability while shrinking or exiting operations in other parts of the world. Key to its growth strategy in Greater China is capitalizing on the rising affluence in the world’s second-largest economy.\nThe London-based bank owns about 62% of Hang Seng.","news_type":1},"isVote":1,"tweetType":1,"viewCount":866,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":814948146,"gmtCreate":1630752010585,"gmtModify":1676530390361,"author":{"id":"3583662534350147","authorId":"3583662534350147","name":"Lhgoh","avatar":"https://static.tigerbbs.com/1c2aee9a5977b03cf1fb62e2691c9aee","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583662534350147","authorIdStr":"3583662534350147"},"themes":[],"htmlText":"Patience","listText":"Patience","text":"Patience","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/814948146","repostId":"812704397","repostType":1,"repost":{"id":812704397,"gmtCreate":1630622463819,"gmtModify":1676530356432,"author":{"id":"4087255023642500","authorId":"4087255023642500","name":"LittlePotato","avatar":"https://static.itradeup.com/news/b42a82452aff8b563c6f332c56ef8a9a","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087255023642500","authorIdStr":"4087255023642500"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>amazing","listText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>amazing","text":"$Bank of America(BAC)$amazing","images":[{"img":"https://static.tigerbbs.com/6d44bc628b4a582065dc666692022ba7","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/812704397","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":680,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810401281,"gmtCreate":1629989553643,"gmtModify":1676530195069,"author":{"id":"3583662534350147","authorId":"3583662534350147","name":"Lhgoh","avatar":"https://static.tigerbbs.com/1c2aee9a5977b03cf1fb62e2691c9aee","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583662534350147","authorIdStr":"3583662534350147"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>come on","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>come on","text":"$Alibaba(BABA)$come on","images":[{"img":"https://static.tigerbbs.com/7a2fb32cad18084c3c3d3ed5b1a9cbc2","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/810401281","isVote":1,"tweetType":1,"viewCount":682,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":835269245,"gmtCreate":1629721244687,"gmtModify":1676530110730,"author":{"id":"3583662534350147","authorId":"3583662534350147","name":"Lhgoh","avatar":"https://static.tigerbbs.com/1c2aee9a5977b03cf1fb62e2691c9aee","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583662534350147","authorIdStr":"3583662534350147"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/835269245","repostId":"1175882737","repostType":4,"repost":{"id":"1175882737","kind":"news","pubTimestamp":1629719052,"share":"https://ttm.financial/m/news/1175882737?lang=&edition=fundamental","pubTime":"2021-08-23 19:44","market":"us","language":"en","title":"Stem Is a Play on the Future of Batteries. Its Stock Could Double.","url":"https://stock-news.laohu8.com/highlight/detail?id=1175882737","media":"Barrons","summary":"Batteries are being supersized as renewables take an ever-larger share of the world’s energy generat","content":"<p>Batteries are being supersized as renewables take an ever-larger share of the world’s energy generation. And that’s great news for power-storage provider Stem.</p>\n<p>Renewable energy, which accounted for just 10% of U.S. energy production 20 years ago, generates 20% today, and that share should continue to rise as the U.S., like other countries, gradually phases out fossil fuels in favor of more environmentally friendly alternatives.</p>\n<p>The Biden administration wants to hit 100% carbon-free generation by 2035. For that to work, however, utilities would need plenty of highcapacity batteries to store the energy produced by wind turbines and solar panels when the gales are blowing and the sun is shining, so there is electricity to distribute when they’re not.</p>\n<p>That’s where Stem (ticker: STEM) comes in. The San Francisco–based company installs arrays of large batteries for utilities and industrial companies and sells software to manage them.</p>\n<p>The company is small; its market value is about $2.8 billion after dropping 20%, to a recent $21.34, since its merger with Star Peak Energy Transition in April. But Stem already has dozens of utility customers and has deployed more than 900 systems that combined could produce a gigawatt hour of electricity, enough to power 100 homes for a year. A bet on Stem is a bet on renewable energy’s future.</p>\n<p><img src=\"https://static.tigerbbs.com/9c291c83e8cf6597cb7451bc703a1549\" tg-width=\"606\" tg-height=\"548\" width=\"100%\" height=\"auto\"></p>\n<p>Stem doesn’t make batteries, for good reason. The lithium-ion batteries used for commercial storage applications have become commodities, in a market dominated by a few huge players, such as LG Chem(051910.Korea) and Contemporary Amperex Technology(300750.China).</p>\n<p>Battery arrays can replace the expensive natural-gas-fed power plants that many utilities use to meet spikes in demand, says Credit Suisse analyst Maheep Mandloi, who notes that the transition has been under way for a couple of years. In 2020, for instance, Australia famously bought a huge battery array from Tesla(TSLA) to store electricity from a large wind farm in a power-starved area of the country.</p>\n<p>Power prices vary throughout the day. Industrial companies typically pay a rate based on the peak price they hit each month. Falling battery costs have led many to install solar-energy systems with power-storage capability. These can replace some utility-generated electricity, especially during periods of peak usage.</p>\n<p><img src=\"https://static.tigerbbs.com/13e2e491a314ac269dac7c14bffbac36\" tg-width=\"974\" tg-height=\"636\" width=\"100%\" height=\"auto\"></p>\n<p>Employing renewable power and batteries to replace energy from a utility is known as going “behind the meter.” Stem installs the batteries and provides software that uses artificial intelligence and machine learning to optimize their performance, by automatically switching among battery power, onsite generation, and grid power. “Industrial companies can save up to 30%,” says Stem CEO John Carrington.</p>\n<p>Stem’s stock could benefit if tax credits for installing battery storage become available in a Biden green-energy plan, encouraging people to buy solar-power systems the way credits encourage purchases of electric cars. The stationary power industry will be seeking federal tax support in the coming months.</p>\n<p>But even without tax breaks, Stem shares look attractive. Mandloi has an Outperform rating on them, largely for Stem’s 30% market share in the behind-the-meter market, where it competes with companies such as Enel X, part of the Enel Group (ENEL.Italy), and in energy software, with AutoGrid.</p>\n<p>Stem had sales of $19 million in the second quarter and is expected to have $147 million for the entire year, up from about $36 million in 2020. Industrial companies make up most of its business, with utilities and other power generators accounting for the balance.</p>\n<p>Stem, recently trading at about eight times estimated 2022 enterprise value to sales, looks expensive. But its revenue is expected to more than double in 2022, to $315 million. The Russell 1000 Growth Index trades around four times estimated 2022 sales, but its revenue is projected to rise about 9% from 2021 to 2022. Stem also has $475 million in cash, received when it went public in April through a merger with Star Peak, a special public acquisition company.</p>\n<p>Mandloi assumes Stem battery shipments will grow at 48% a year, on average. By 2030, he says, it should be generating $757 million annually in earnings before interest, taxes, depreciation, and amortization, or Ebitda. That gives him a price target of $48 a share, more than double Friday’s close, or 28 times 2023 Ebitda estimates. On the same basis,Enphase Energy(ENPH), another renewable-technology company, trades at 35 times 2023 estimates.</p>\n<p>Potential rewards don’t come without risks, and Stem has plenty. For one, it won’t be profitable until 2022, at the earliest. And if sales of electric vehicles surge, that could limit the supply of batteries for stationary power applications. And competition almost certainly will ramp up.</p>\n<p>Many of those concerns may already be reflected in the stock’s slide since the merger. The $475 million it has, however, should help carry the company until it starts generating positive cash flow from operations.</p>\n<p>“You need a good balance sheet,” says CEO Carrington. “Counterparties look at you and say, ‘Are you going to be here in 20 years?’ ” Since Stem acquired the added cash, he says, business inquiries have picked up. Don’t be surprised if the stock does, too.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stem Is a Play on the Future of Batteries. Its Stock Could Double.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStem Is a Play on the Future of Batteries. Its Stock Could Double.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-23 19:44 GMT+8 <a href=https://www.barrons.com/articles/stem-stock-price-future-of-batteries-51629490431?mod=hp_LEADSUPP_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Batteries are being supersized as renewables take an ever-larger share of the world’s energy generation. And that’s great news for power-storage provider Stem.\nRenewable energy, which accounted for ...</p>\n\n<a href=\"https://www.barrons.com/articles/stem-stock-price-future-of-batteries-51629490431?mod=hp_LEADSUPP_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STEM":"Stem Inc."},"source_url":"https://www.barrons.com/articles/stem-stock-price-future-of-batteries-51629490431?mod=hp_LEADSUPP_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175882737","content_text":"Batteries are being supersized as renewables take an ever-larger share of the world’s energy generation. And that’s great news for power-storage provider Stem.\nRenewable energy, which accounted for just 10% of U.S. energy production 20 years ago, generates 20% today, and that share should continue to rise as the U.S., like other countries, gradually phases out fossil fuels in favor of more environmentally friendly alternatives.\nThe Biden administration wants to hit 100% carbon-free generation by 2035. For that to work, however, utilities would need plenty of highcapacity batteries to store the energy produced by wind turbines and solar panels when the gales are blowing and the sun is shining, so there is electricity to distribute when they’re not.\nThat’s where Stem (ticker: STEM) comes in. The San Francisco–based company installs arrays of large batteries for utilities and industrial companies and sells software to manage them.\nThe company is small; its market value is about $2.8 billion after dropping 20%, to a recent $21.34, since its merger with Star Peak Energy Transition in April. But Stem already has dozens of utility customers and has deployed more than 900 systems that combined could produce a gigawatt hour of electricity, enough to power 100 homes for a year. A bet on Stem is a bet on renewable energy’s future.\n\nStem doesn’t make batteries, for good reason. The lithium-ion batteries used for commercial storage applications have become commodities, in a market dominated by a few huge players, such as LG Chem(051910.Korea) and Contemporary Amperex Technology(300750.China).\nBattery arrays can replace the expensive natural-gas-fed power plants that many utilities use to meet spikes in demand, says Credit Suisse analyst Maheep Mandloi, who notes that the transition has been under way for a couple of years. In 2020, for instance, Australia famously bought a huge battery array from Tesla(TSLA) to store electricity from a large wind farm in a power-starved area of the country.\nPower prices vary throughout the day. Industrial companies typically pay a rate based on the peak price they hit each month. Falling battery costs have led many to install solar-energy systems with power-storage capability. These can replace some utility-generated electricity, especially during periods of peak usage.\n\nEmploying renewable power and batteries to replace energy from a utility is known as going “behind the meter.” Stem installs the batteries and provides software that uses artificial intelligence and machine learning to optimize their performance, by automatically switching among battery power, onsite generation, and grid power. “Industrial companies can save up to 30%,” says Stem CEO John Carrington.\nStem’s stock could benefit if tax credits for installing battery storage become available in a Biden green-energy plan, encouraging people to buy solar-power systems the way credits encourage purchases of electric cars. The stationary power industry will be seeking federal tax support in the coming months.\nBut even without tax breaks, Stem shares look attractive. Mandloi has an Outperform rating on them, largely for Stem’s 30% market share in the behind-the-meter market, where it competes with companies such as Enel X, part of the Enel Group (ENEL.Italy), and in energy software, with AutoGrid.\nStem had sales of $19 million in the second quarter and is expected to have $147 million for the entire year, up from about $36 million in 2020. Industrial companies make up most of its business, with utilities and other power generators accounting for the balance.\nStem, recently trading at about eight times estimated 2022 enterprise value to sales, looks expensive. But its revenue is expected to more than double in 2022, to $315 million. The Russell 1000 Growth Index trades around four times estimated 2022 sales, but its revenue is projected to rise about 9% from 2021 to 2022. Stem also has $475 million in cash, received when it went public in April through a merger with Star Peak, a special public acquisition company.\nMandloi assumes Stem battery shipments will grow at 48% a year, on average. By 2030, he says, it should be generating $757 million annually in earnings before interest, taxes, depreciation, and amortization, or Ebitda. That gives him a price target of $48 a share, more than double Friday’s close, or 28 times 2023 Ebitda estimates. On the same basis,Enphase Energy(ENPH), another renewable-technology company, trades at 35 times 2023 estimates.\nPotential rewards don’t come without risks, and Stem has plenty. For one, it won’t be profitable until 2022, at the earliest. And if sales of electric vehicles surge, that could limit the supply of batteries for stationary power applications. And competition almost certainly will ramp up.\nMany of those concerns may already be reflected in the stock’s slide since the merger. The $475 million it has, however, should help carry the company until it starts generating positive cash flow from operations.\n“You need a good balance sheet,” says CEO Carrington. “Counterparties look at you and say, ‘Are you going to be here in 20 years?’ ” Since Stem acquired the added cash, he says, business inquiries have picked up. Don’t be surprised if the stock does, too.","news_type":1},"isVote":1,"tweetType":1,"viewCount":709,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}